Home-based screening for biliary atresia using infant stool colour cards: A large-scale prospective cohort study and cost-effectiveness analysis

Journal of Medical Screening

Volumn 21, Issue 3, 2014, Pages 126-132

  Schreiber, Richard A ^a,c,d   Masucci, Lisa ^e   Kaczorowski, Janusz ^b   Collet, J P ^c,d   Lutley, Pamela ^c   Espinosa, Victor ^d   Bryan, Stirling ^c,e  

^a Division of Pediatric Gastroenterology Hepatology and Nutrition   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

Biliary atresia; Cost effectiveness; Markov modeling; Newborn screening

Indexed keywords

ARTICLE; BILE DUCT ATRESIA; COLOR; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM EXAMINATION; ECONOMICS; FECES; HUMAN; MARKOV MODELLING; NEWBORN; NEWBORN SCREENING; PROSPECTIVE STUDY; SELF CARE;

BILIARY ATRESIA; COST EFFECTIVENESS; MARKOV MODELLING; NEWBORN SCREENING;

BILIARY ATRESIA; COLOR; COST-BENEFIT ANALYSIS; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; FECES; HUMANS; INFANT, NEWBORN; PROSPECTIVE STUDIES; SELF CARE;

EID: 84908495621     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141314542115     Document Type: Article

References (25)

1. Hartley JL, Davenport M, Kelly DA. Biliary Atresia. Lancet 2009; 374:1704–13.
2. Balistreri WF, Grand R, Hoofnagle JH, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology 1996; 23:1682–92.
3. Guttman O, Roberts EA, Schreiber RA, et al. Biliary atresia with associated structural malformations in Canadian infants. Liv Int 2011; 31: 1485–93.
4. Schreiber RA, Barker CC, Roberts EA, et al. Biliary atresia: the Canadian experience. J Pediatr 2007; 151:659–65.
5. Sokol RJ, Shepherd RW, Superina R, et al. Screening and outcomes in biliary atresia: Summary of a National Institutes of Health workshop. Hepatol 2007; 46:566–81.
6. Serinet MO, Wildhaber BE, Broue P, et al. Impact of age at Kasai operation on its results in late childhood and adolescence: a rational for biliary atresia screening. Pediatr 2009; 123: 1280–86.
7. Serinet MO, Broué P, Jacquemin E, et al. Management of patients with biliary atresia in France: results of a decentralized policy 1986–2002. Hepatol 2006; 44:75–84.
8. Wildhaber BE, Majno P, Mayr J, et al. Biliary atresia: Swiss national study, 1994–2004. J Pediatr Gastroenterol Nutr 2008; 46:299–307.
9. De Vries W, Homan-Van der venn J, Hulscher JB, et al. Netherlands Study Group of Biliary Atresia Registry. Twenty-year transplant-free survival rate among patients with biliary atresia. Clin Gastro & Hepatol 2011; 9:1086–91.
10. Davenport M, Ong E, Shariff K, et al. Biliary atresia in England and Wales: results of centralization and new benchmark. J Ped Surg 2011; 46:1689–94.
11. Chitsaz E, Schreiber RA, Collet JP, et al. Biliary atresia: the timing needs a changin’. CJPH 2009; 100:475–77.
12. Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool colour card in Taiwan. Pediatr 2006; 117:1147–54.
13. Cheng HH, Chang MH, Chen HL, et al. Universal screening for biliary atresia using an infant stool colour card in Taiwan. Hepatol 2008; 47: 1233–40.
14. Lien TH, Chang MH, Wu JF, et al. Effects of the infant stool card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatol 2011; 53: 202–08.
15. Barton P, Bryan S, Robinson S. Modeling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy 2004 Apr; 9(2): 110–8.
16. Life Expectancy and Deaths. Canada: Statistics Canada; 2002 [updated 2002; cited]; Available from: statcan.gc.ca.
17. Briggs A, Claxton K, Sculpher M. Decision Modeling for Health Economic Evaluation. New York: Oxford University Press Inc, 2006.
18. Watson MS, Mann MY, Lloyd-Puryear MA, et al. Newborn screening: toward a uniform screening panel and system. Executive summary. Genet Med 2006; 8:S1–11.
19. Mushtaq I, Logan S, Morris M, et al. Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ 1999; 319: 471–77.
20. Powell JE, Keffler S, Kelly DA, et al. Population screening for neonatal liver disease: potential for a community-based programme. J Med screen 2003; 10:112–16.
21. Harpavat S, Finegold MJ, Karpen SJ. Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatr 2011; 128:e1428–33.
22. Maki T, Sumazaki R, Matsui M. Mass screening for biliary atresia. Jpn J Pediatr Surg 1999; 31:242–46.
23. Wildhaber BE. reening for biliary atresia: Swiss stool colour card. Hepatol 2011; 54:367–8.
24. Bezerra JA. liary atresia in Brazil: where are we and where are we going. Pediatr(Rio J) 2010; 86:445–447.
25. Utterson EC, Shepherd RW, Sokol RJ, Bucuvalas J, Magee JC, McDiarmid SV, et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005 Aug; 147(2): 180–5.